NASDAQ · Medical - Devices

IRMD (IRMD) Stock

$86.22 -0.19% NASDAQ: IRMD Healthcare

Valuation

MetricValue
Price$86.22
Market Cap$1.10B
P/E Ratio47.46
P/B Ratio10.85
P/S Ratio12.79
EPS (TTM)$1.83
52-Week High$107.90
52-Week Low$67.84
Dividend Yield0.93%

Financials & Margins

MetricValue
ROE23.45%
ROA20.05%
ROCE26.04%
Gross Margin76.84%
Operating Margin32.40%
Net Margin26.70%
Debt/Equity0.00
Current Ratio8.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$53.0M$66.0M$73.0M$84.0M
Operating Profit$10.0M$16.0M$20.0M$22.0M$26.0M
Net Profit$9.0M$13.0M$17.0M$19.0M$22.0M
EPS$0.74$1.02$1.35$1.50$1.75
Op Margin23.5%29.3%30.6%30.0%31.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$83.0M$86.0M$92.0M$98.0M$109.0M
Total Liabilities$11.0M$12.0M$21.0M$12.0M$14.0M
Cash$62.0M$58.0M$50.0M$52.0M$51.0M
Borrowings$2.0M$2.0M$2.0M$0$0

Latest News

Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing MT Newswires · Jun 4, 2026 Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple Simply Wall St. · Jun 3, 2026 IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It Motley Fool · Jun 2, 2026 Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing MT Newswires · May 28, 2026 Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report Insider Monkey · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$11.0M$10.0M$13.0M$26.0M$25.0M
Investing Cash Flow$0$-3.0M$-16.0M$-17.0M$-16.0M
Financing Cash Flow$0$0$0$-1.0M$-3.0M
Net Cash Flow$12.0M$-4.0M$-8.0M$2.0M$-1.0M
Free Cash Flow$11.0M$8.0M$5.0M$18.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio4.07
EV / EBITDA33.59
FCF Yield2.26%
Quick Ratio8.13
Interest Coverage0.00
Return 1Y66.96%
Return 3Y116.15%
Return 5Y199.20%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $5.60 +0.18% 8.52 $761.92M 0.00%
AXGN $50.02 -1.46% 60.40 $2.69B 0.00%
CRON $3.38 +0.30% -131.00 $1.26B 0.00%
CTEV $39.39 -1.12% -2.21 $671.43M 0.00%
GDRX $3.49 -0.02% 28.44 $1.21B 0.00%

About IRMD

IRMD is led by CEO Roger E. Susi, employs 160 people, headquartered in US, publicly traded since 2014.

IRMD stock trades at $86.22 with a market capitalization of $1.10B. The stock is valued at a price-to-earnings (P/E) ratio of 47.46, price-to-book of 10.85, price-to-sales of 12.79. Over the past 52 weeks the stock has ranged between $67.84 and $107.90, and currently trades 20.1% below its 52-week high. It pays a dividend yielding 0.93%.

On profitability, IRMD generates a return on equity (ROE) of 23.45% — well above the market average, a sign of a high-quality business, return on capital employed of 26.04%, an operating margin of 32.40%, a net profit margin of 26.70%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides